Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases Jae-Kyung LeeJosephine Bou Dagher Review Article 22 February 2016 Pages: 545 - 549
Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers Michael P. HayesDavid L. Roman Review Article 29 February 2016 Pages: 550 - 559
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer Katelin E. AhlersBandana ChakravartiRory A. Fisher Review Article 22 March 2016 Pages: 560 - 572
Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling Robert N. SchuckJoseph A. Grillo Review Article 24 February 2016 Pages: 573 - 577
Regulatory Perspectives on Strength-Dependent Dissolution Profiles and Biowaiver Approaches for Immediate Release (IR) Oral Tablets in New Drug Applications Sandra Suarez-SharpPoonam R. DelvadiaPaul Seo Review Article 29 February 2016 Pages: 578 - 588
Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination Christopher R. JonesOliver J. D. HatleyAmin Rostami-Hodjegan Review Article 10 March 2016 Pages: 589 - 604
Recent Advances in Application of Pharmacogenomics for Biotherapeutics Pramod B. Mahajan Mini-Review 23 March 2016 Pages: 605 - 611
BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements Barbara M. DavitIsadore KanferJean-Michel Cardot Mini-Review 04 March 2016 Pages: 612 - 618
Evaluating In Vivo-In Vitro Correlation Using a Bayesian Approach Junshan QiuMarilyn MartinezRam Tiwari Research Article 19 February 2016 Pages: 619 - 634
Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design Katie F. MaassChethana KulkarniK. Dane Wittrup Research Article 24 February 2016 Pages: 635 - 646
Controlled Release of Chitosan and Sericin from the Microspheres-Embedded Wound Dressing for the Prolonged Anti-microbial and Wound Healing Efficacy Pornanong AramwitRungnapha YamdechSumate Ampawong Research Article 02 March 2016 Pages: 647 - 658
Reserpine Inhibit the JB6 P+ Cell Transformation Through Epigenetic Reactivation of Nrf2-Mediated Anti-oxidative Stress Pathway Bo HongZhengyuan SuAh-Ng Tony Kong Research Article 17 March 2016 Pages: 659 - 669
Analytical Similarity Assessment in Biosimilar Studies Shein-Chung ChowFuyu SongHe Bai Research Article 12 February 2016 Pages: 670 - 677
The Population Pharmacokinetics of d-β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate Vittal ShivvaPete J. CoxStephen B. Duffull Research Article 18 February 2016 Pages: 678 - 688
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics A. SinglaR. BansalAnurag S. Rathore Research Article 22 February 2016 Pages: 689 - 702
Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors Núria Buil-BrunaMarion DehezIñaki F. Trocóniz Research Article 23 February 2016 Pages: 703 - 712
Pharmacodynamic Model of Hepcidin Regulation of Iron Homeostasis in Cynomolgus Monkeys Wojciech KrzyzanskiJim J. XiaoJuan Jose Perez-Ruixo Research Article 25 February 2016 Pages: 713 - 727
Pediatric Biopharmaceutical Classification System: Using Age-Appropriate Initial Gastric Volume Ramzi Shawahna Research Article 02 March 2016 Pages: 728 - 736
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents Hao ChengZhiliang XieKenneth K. Chan Research Article 04 March 2016 Pages: 737 - 745
Does the Systemic Plasma Profile Inform the Liver Profile? Analysis Using a Physiologically Based Pharmacokinetic Model and Individual Compounds Rui LiTristan S. MaurerHugh A. Barton Research Article 07 March 2016 Pages: 746 - 756
Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage Rosa ChanChun-yu WeiLeslie Z. Benet Research Article 07 March 2016 Pages: 757 - 766
Development of a Physiologically Based Pharmacokinetic Model to Predict Disease-Mediated Therapeutic Protein–Drug Interactions: Modulation of Multiple Cytochrome P450 Enzymes by Interleukin-6 Xiling JiangYanli ZhuangHonghui Zhou Research Article 09 March 2016 Pages: 767 - 776
A Kinetic Degradation Study of Curcumin in Its Free Form and Loaded in Polymeric Micelles Ornchuma NaksuriyaMies J. van SteenbergenWim E. Hennink Research Article 01 April 2016 Pages: 777 - 787
Tissue Penetration of a Novel Spectinamide Antibiotic for the Treatment of Tuberculosis Dora Babu MadhuraAshit TrivediBernd Meibohm Brief/Technical Note 16 March 2016 Pages: 788 - 791
Erratum to: Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations? Dorys Argelia DiazStephen T. ColganLeslie Van Alstine Erratum 04 November 2015 Pages: 792 - 792